Cardiometabolic disease is used as an umbrella term for all the above cases, and severity of cardiometabolic disease refers, in this manuscript, to the progression from single risk factors such as obesity to overt T2D and cardiac phenotype (ischemic heart disease and heart failure)
Wei et al., 2020
Why Alcohol and GLP-1 Injections Dont Mix Well GLP-1 injections are designed to help regulate blood sugar, manage appetite, and support weight loss goals
However, it's important to note that these markers can also be elevated in other conditions, particularly renal impairment, so results must be interpreted carefully
Other possible risks include dizziness, fatigue, headache, stomach discomfort, bloating, indigestion, gas pains, and burping
It pulls relevant links and resources